About Cancer Targeted Technology
Cancer Targeted Technology is a company based in Woodinville (United States) founded in 2006. It operates as a HealthTech. The company has 4 employees as of December 31, 2024. Cancer Targeted Technology offers products and services including CTT1057, CTT1403, and CTT2274. Cancer Targeted Technology operates in a competitive market with competitors including ImaginAb, MDxHealth, AC Immune, Opko Health and Life Length, among others.
- Headquarter Woodinville, United States
- Employees 4 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Cancer Targeted Technology
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$400 K (USD), Grant
Sep 02, 2024
-
Investors
NIH
& 2 more
-
Employee Count
4
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cancer Targeted Technology
Cancer Targeted Technology offers a comprehensive portfolio of products and services, including CTT1057, CTT1403, and CTT2274. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for PET imaging in prostate cancer diagnosis.
Developed for radiotherapeutic treatment of prostate cancer.
Designed for chemotherapeutic treatment of prostate cancer.
Funding Insights of Cancer Targeted Technology
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $400,000
-
First Round
First Round
(28 Sep 2010)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - Cancer Targeted Technology | Valuation |
investors |
|
| Sep, 2021 | Amount | Grant - Cancer Targeted Technology | Valuation |
investors |
|
| Aug, 2020 | Amount | Grant - Cancer Targeted Technology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cancer Targeted Technology
Cancer Targeted Technology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and NIH SBIR/STTR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cancer Targeted Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cancer Targeted Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cancer Targeted Technology Comparisons
Competitors of Cancer Targeted Technology
Cancer Targeted Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, MDxHealth, AC Immune, Opko Health and Life Length, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Epigenetic tests for personalized cancer assessment and treatment.
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic products for prostate cancer assessment are provided.
|
|
| domain | founded_year | HQ Location |
Provides telomere length analysis technology for diagnosis
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cancer Targeted Technology
Frequently Asked Questions about Cancer Targeted Technology
When was Cancer Targeted Technology founded?
Cancer Targeted Technology was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Where is Cancer Targeted Technology located?
Cancer Targeted Technology is headquartered in Woodinville, United States. It is registered at Woodinville, Washington, United States.
How many employees does Cancer Targeted Technology have?
As of Dec 31, 2024, the latest employee count at Cancer Targeted Technology is 4.
What does Cancer Targeted Technology do?
Cancer Targeted Technology is engaged in the design and patenting of small molecule drugs for cancer, with a focus on diagnostic imaging and therapeutic solutions. The company develops products like CTT1057 for PET imaging, CTT1403 for radiotherapeutic treatment, and CTT2274 for chemotherapeutic treatment, primarily targeting prostate cancer. Their work spans the healthcare and biotechnology sectors, aiming to advance cancer care through innovative drug conjugates and diagnostic agents.
Who are the top competitors of Cancer Targeted Technology?
What products or services does Cancer Targeted Technology offer?
Cancer Targeted Technology offers CTT1057, CTT1403, and CTT2274.